Kare Schultz earned $107m during Teva tenure

Government remuneration figures for 2022 had been revealed yesterday within the invitation to Teva’s annual shareholders assembly on June 15. Schultz, who stepped down on the finish of 2022 and was changed by Richard Francis, acquired related remuneration final 12 months as lately: a fundamental annual wage of $2 million, capital remuneration of $10 million, different remuneration of $2.8 million and $705,000 in different funds for housing, relocation, automotive and so on.).

RELATED ARTICLES

Teva reviews heavy losses, sees minimal 2023 progress

Teva’s new CEO: There’s a possibility to return to progress

Kare Schultz alerts finish to time at Teva

Although he’s now not CEO, Schultz will obtain $16 million throughout 2023 – $2 million compensation for ending his employment, $10 million capital remuneration and $4 million as a part of his dedication to not compete with Teva.

Along with Schultz, 4 different senior executives every acquired pay of about $3.9-4 million in 2022 – CFO Eli Kalif, EVP North America industrial Dr. Sven Dethlefs, EVP Worldwide Markets industrial Mark Sabag and EVP International Operations Eric Drapé. Chairman Dr. Sol Barer acquired $540,000 (together with $285,000 in capital remuneration) and the remainder of the board of administrators acquired $310-360,000).

Barer and Janet Vergis will search re-election to the board on the shareholders assembly in June. Chemi Peres, who has served on the board since 2017 and Jean-Michel Halfon who has served since 2014, will probably be stepping down whereas Microsoft CVP and Microsoft Israel R&D Heart basic supervisor Michal Braverman-Blumenstyk will be a part of the board, topic to the approval of the shareholders.

Revealed by Globes, Israel enterprise information – en.globes.co.il – on April 20, 2023.

© Copyright of Globes Writer Itonut (1983) Ltd., 2023.